Mesenchymal Stem Cells Market Share, Size, Trends, Industry Analysis Report, By Products & Services, By Type; By Source Of Isolation, By Indication Outlook, By Application, By Region; Segment Forecast, 2022 - 2030
- Published Date:Mar-2019
- Pages: 110
- Format: PDF
- Report ID: PM1565
- Base Year: 2021
- Historical Data: 2018-2020
Report Outlook
The global mesenchymal stem cells market was valued at USD 2.49 billion in 2021 and is expected to grow at a CAGR of 12.9% during the forecast period. The growth of the mesenchymal market is attributed to the escalated need for pluripotent tissue that is needed in disease modeling, drug discovery, and development, stem cell banking, tissue engineering, toxicology, others.
Know more about this report: request for sample pages
Moreover, increasing cases and unavailability of proper treatment for genetic and rare diseases globally has led to the increase in the demand for these products& services, and manufacturers are involved in demand fulfillment. Mesenchymal tissue is adult cells/ multipotent cells, can be isolated from various sources, mainly from bone marrow, and are capable to differentiate into various types of cells. These cells are mainly involved in the formation and repair of skeletal tissues and for the treatment of diseases like neurological disorders, cardiac ischemia, diabetes.
Know more about this report: request for sample pages
Industry Dynamics
Growth Drivers
The need for genetic and non-genetic disease treatment is the key factor driving the growth of the global mesenchymal stem cells market. The widespread applications of these cells along with the better therapeutic results/positive results have elevated the demand for mesenchymal cells. The exponential rise in pluripotent treatment, ongoing research worldwide, huge implications in the field of regenerative medicine, and the constantly evolving landscape of stem cell therapies are considered as some of the growth drivers of this field. The continuous evolution and advancements in stem cell culture and cryopreservation techniques have enabled companies in the maximum revenue generation for workers.
Furthermore, people all over the world are required to make aware of preserving mesenchymal tissue as fast as possible to deal with this global pandemic. Additionally, to provide better and more effective treatments to patients, the rapid and sustainable development of mesenchymal tissue is significantly contributing to the segment’s growth.
Report Segmentation
The market is primarily segmented based on products & services, type, source of isolation, indication, by application, and region.
|
By Products & Services |
By Type |
By Source of Isolation |
By Indication |
By application |
By Region |
|
|
|
|
|
|
Know more about this report: request for sample pages
Insight by Product Type
Based upon product & services type, the market is segmented into workflow type, product type, and services. Of all, the cells and cell lines segment held the largest share in the global mesenchymal market in 2021, owing to the various initiative steps taken by industry players such as new product development, adoption of new technologies, business expansion, and collaborations with industrial and commercial sectors.
The stem cells products such as the kits, media, and reagents segment are expected to show the highest growth rate and are in high demand in the research and development laboratories, educational, non-educational, and industrial sectors. Furthermore, there is a huge demand for the kits, media, and reagents in the healthcare industries due to continuous research work and study on stem cells which would complement the segment’s growth.
Insight by Type
The autologous segment is expected to show a CAGR growth of 13.2% during the forecast period. Studies have shown positive results from the treatment of multiple system atrophy using MSCs. The allogeneic segment is dominating the industry and accounts for the largest share in the MSCs market due to its low immunogenicity & immune-suppressive properties. The immunosuppressive property supports successful allogenic MSCs transplantations.
Insight by Source of Isolation
Based on the source of isolation, the global market is segmented into bone marrow, cord blood, peripheral blood, fallopian tube, fetal liver, lungs, adipose tissues. The bone marrow segment is dominating the market and accounts for the largest share. These cells are pluripotent and can be differentiated into bones, cartilage, tendons, fibroblasts, fat, cardiac muscle cells, and endothelial cells.
Insight by Indication
Cardiovascular disease segment is dominating the market and accounts for the largest revenue share, in 2021. Studies have shown the successful transplantation of mesenchymal tissue for cardiovascular treatment due to the properties of mesenchymal tissue such as inhibiting fibrosis, reducing the level of inflammation, and promoting angiogenesis.
Insight by Application
Tissue engineering segment is expected to witness the highest CAGR during the forecast period, as mesenchymal tissue has been emerged as a major therapeutic approach in tissue engineering due to its capacity of high expansion, self-renewal, and reduced tumorigenicity Moreover, the disease modeling segment is expected to contribute the largest revenue, in 2020, as people all over all the world are rapidly demanding for mesenchymal stem cells market for curing genetic diseases.
Geographic Overview
Geographically, North America is the largest revenue contributor in the global market due to the growth of pandemics massively in the region. The demand for mesenchymal tissue has been exceeded in the U.S. for the treatment of various life-threatening diseases. Several major companies involved in the supply and commercialization of mesenchymal stem cells are situated in the United States. Additionally, the availability of mesenchymal tissue therapies for the treatment of life-threatening diseases is another factor in the growth of the MSCs market in North America.
Additionally, in European countries, stem cells research and development facilities are coupled with the investments and funding programs by major market players, various public and private organizations. As a result, the mesenchymal tissue research and development sector is expected to bolster the growth of the region.
Furthermore, countries like the Asia Pacific are expected to create a strong competitive environment for other countries in the forecast period. Moreover, Asia-Pacific is expected to witness substantial growth in the mesenchymal stem cells market. Unavailability of financial support for major surgeries, limited access to healthcare, lack of healthcare-related awareness among people has turned everyone towards the adoption of stem cell therapies.
Competitive Insight
Some of the major players operating include American Type Culture Collection, Axol Biosciences, BrainStorm Cell, Celprogen Inc, Cyagen Biosciences Inc, Cytori Therapeutics, Lonza AG, PromoCell GmbH, ScienCell Research Laboratories, Smith+Nephew, STEMCELL Technologies Inc, Stemedica Cell Technologies Inc, Thermo Fisher Scientific.
Mesenchymal Stem Cells Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2021 |
USD 2.49 billion |
|
Revenue forecast in 2030 |
USD 7.25 billion |
|
CAGR |
12.9% from 2022 - 2030 |
|
Base year |
2021 |
|
Historical data |
2018 - 2020 |
|
Forecast period |
2022 - 2030 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2022 to 2030 |
|
Segments covered |
By Products & Services, By Type, By Source of Isolation, By Indication, By Application, By Region. |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Key Companies |
American Type Culture Collection, Axol Biosciences, BrainStorm Cell, Celprogen Inc, Cyagen Biosciences Inc, Cytori Therapeutics, Lonza AG, PromoCell GmbH, ScienCell Research Laboratories, Smith+Nephew, STEMCELL Technologies Inc, Stemedica Cell Technologies Inc, Thermo Fisher Scientific |
